Sinan Ahmed D. Dheyauldeen
- Consultant; MD, PhD
Publications 2024
Definition of sinonasal and otological exacerbation in patients with primary ciliary dyskinesia: an expert consensus
ERJ Open Res, 10 (6)
DOI 10.1183/23120541.00218-2024, PubMed 39698064
Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study
ERJ Open Res, 10 (2)
DOI 10.1183/23120541.00932-2023, PubMed 38444659
Publications 2023
Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia
JAMA Otolaryngol Head Neck Surg, 149 (7), 587-596
DOI 10.1001/jamaoto.2023.0841, PubMed 37166807
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
Laryngoscope Investig Otolaryngol, 9 (1), e1196
DOI 10.1002/lio2.1196, PubMed 38362186
Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study
Clin Exp Otorhinolaryngol, 16 (4), 407-412
DOI 10.21053/ceo.2023.01130, PubMed 38056830
Sinonasal disease among patients with primary ciliary dyskinesia: an international study
ERJ Open Res, 9 (3)
DOI 10.1183/23120541.00701-2022, PubMed 37228283
Endoscopic four-hands technique for pituitary tumours
Tidsskr Nor Laegeforen, 143 (9)
DOI 10.4045/tidsskr.22.0693, PubMed 37341404
Publications 2020
Otorhinolaryngologists and the SARS-CoV-2 virus
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0423, PubMed 32602325
Otorhinolaryngologists and the SARS-CoV-2 virus
Tidsskr. Nor. Laegeforen., 140 (10), 966-967
Publications 2019
Intranasal bevacizumab injections improve quality of life in HHT patients
Laryngoscope, 130 (5), E284-E288
DOI 10.1002/lary.28179, PubMed 31287573
Publications 2018
Monocytes accumulate in the airways of children with fatal asthma
Clin Exp Allergy, 48 (12), 1631-1639
DOI 10.1111/cea.13265, PubMed 30184280
Long-term experience with intranasal bevacizumab therapy
Laryngoscope, 128 (10), 2237-2244
DOI 10.1002/lary.27147, PubMed 29469958
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis
Laryngoscope, 129 (1), E44-E49
DOI 10.1002/lary.27548, PubMed 30329172
Publications 2017
A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu
Allergy Rhinol (Providence), 8 (3), 148-156
DOI 10.2500/ar.2017.8.0216, PubMed 29070272
Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report
Laryngoscope, 128 (3), 593-596
DOI 10.1002/lary.26722, PubMed 28671294
Publications 2016
Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects
J Allergy Clin Immunol, 137 (6), 1872-1881.e12
DOI 10.1016/j.jaci.2015.11.025, PubMed 26851967
Publications 2012
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose
Laryngoscope, 122 (6), 1210-4
DOI 10.1002/lary.23303, PubMed 22565282
Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study
Am J Med Genet A, 158A (6), 1269-78
DOI 10.1002/ajmg.a.35309, PubMed 22529055
Living with hereditary haemorrhagic telangiectasia: coping and psychological distress - a cross-sectional study
Disabil Rehabil, 35 (3), 206-13
DOI 10.3109/09638288.2012.690500, PubMed 22671535
Publications 2011
The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study
Am J Rhinol Allergy, 25 (4), 214-8
DOI 10.2500/ajra.2011.25.3616, PubMed 21819756
Publications 2010
Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
Ann Hematol, 90 (5), 611-2
DOI 10.1007/s00277-010-1063-5, PubMed 20824275